Key result
Long-term administration of olmesartan induced marked proliferative changes in afferent arteriolar smooth muscle cells in Zucker fatty rats.
Why the study?
Does olmesartan induce morphological changes in renal afferent arterioles in Zucker fatty rats?
Does olmesartan induce morphological changes in renal afferent arterioles in Zucker fatty rats?
This is the authors' abstract. We don't add key points for this paper.
INTRODUCTION: The nephro-protective effects of angiotensin II receptor blockers (ARBs) are widely known; however, there are few reports of long-term effects focusing on the renal vessels. We studied afferent arteriolar changes induced by the long-term administration of an ARB. MATERIALS AND METHODS: Thirty-two 6-week-old male Zucker fatty rats (ZFRs) were divided into following four groups (n = 8 in each): ZFR Group and ZFR+High Group fed a standard or high-salt diet, respectively; ZFR+ARB Group and ZFR+High+ARB Group fed a standard or high-salt diet with ARB (Olmesartan, 5 mg/kg/day), respectively. Blood pressure, proteinuria, morphological examinations and glomerular haemodynamics in vivo were studied. RESULTS: Marked proliferative changes in the afferent arteriolar smooth muscle cells (SMCs) were frequently observed in the two groups given ARBs; in the ZFR+ARB group (77.3±10.3%) compared with the two groups without ARB (1.7%, p < 0.005; 1.2%, p < 0.0005) and 37.4±15.6% in the ZFR+High+ARB group. Proteinuria markedly decreased in the groups treated with ARBs, but the glomerular erythrocyte velocities showed no differences. CONCLUSIONS: Our findings indicate that long-term ARB administration induced unusual proliferative changes in SMCs of afferent arterioles of ZFRs. These changes could narrow arteriolar lumens and reduce intraglomerular pressure, but they could cause also irreversible damage to the arterioles.
Answers are grounded in this paper and cite their sources.
Long-term olmesartan administration in Zucker fatty rats induces unusual proliferative changes in afferent arteriolar smooth muscle cells, which may reduce intraglomerular pressure but potentially cause irreversible arteriolar damage.
No takes yet. Share an insight, caveat, or question.
Nakanishi et al. (2011) studied Zucker fatty rats (animal model) (n=32). Olmesartan (ARB) vs. No ARB (standard or high-salt diet alone) was evaluated on Proliferative changes in the afferent arteriolar smooth muscle cells (SMCs) (p=< 0.005). Long-term administration of olmesartan induced marked proliferative changes in afferent arteriolar smooth muscle cells in Zucker fatty rats.
Synapse has enriched 10 related papers. Consider them for comparative context: